Contact us for more information on the VAL-083 Clinical Trials

I am a:

Clinical Trials for VAL-083

VAL-083 is a structurally unique, "first-in-class", small-molecule chemotherapeutic. Based on historical data and our own research, we believe that VAL-083 has the potential to offer physicians and patients a new paradigm in the treatment of Glioblastoma Multiforme (GBM).